court decision on tirzepatide FDA confirms shortage is still over, gives compounders a grace period GLP-1 Drugs: FDA “Re-Confirms” Decision

The clinical reasoning: aspiration is rare but devastating when it happens, and the cost of a 1-week medication pause is minimal

The results showed that tirzepatide was more effective in reducing body weight than semaglutide at all respective doses, reporting figures of -6.2kg, -8.8g, and -11.0kg and for tirzepatide 5.0mg, 10.0mg, and 15.0mg, respectively, versus -2.7kg, -4.4kg, and -5.2kg for semaglutide 0.5mg, 1.0mg, and 2.0mg, respectively

This latter fact is important because A1 astrocytes are thought to be a primary driver of neurotoxicity and neuron death in Alzheimers Disease

L.BuchholzB

AMPK activation promotes glucose uptake, fatty acid oxidation, and mitochondrial biogenesis while suppressing energy-consuming processes during metabolic stress

This option provides convenience and an alternative to traditional weekly injections, perfect for patients who desire an oral regimen